Anteris Technologies Global (NASDAQ:AVR - Get Free Report) announced its quarterly earnings data on Monday. The company reported ($0.58) EPS for the quarter, missing analysts' consensus estimates of ($0.53) by ($0.05), Zacks reports. The company had revenue of $0.62 million during the quarter, compared to analysts' expectations of $0.58 million.
Anteris Technologies Global Price Performance
AVR stock traded up $0.06 during midday trading on Friday, reaching $3.98. The stock had a trading volume of 11,608 shares, compared to its average volume of 208,315. Anteris Technologies Global has a twelve month low of $2.34 and a twelve month high of $8.79. The business has a fifty day simple moving average of $3.72 and a two-hundred day simple moving average of $4.70.
Hedge Funds Weigh In On Anteris Technologies Global
Institutional investors have recently modified their holdings of the stock. JPMorgan Chase & Co. grew its position in shares of Anteris Technologies Global by 9,958.6% in the 2nd quarter. JPMorgan Chase & Co. now owns 1,068,328 shares of the company's stock valued at $4,049,000 after purchasing an additional 1,057,707 shares during the period. Geode Capital Management LLC lifted its stake in Anteris Technologies Global by 154.3% in the 2nd quarter. Geode Capital Management LLC now owns 420,427 shares of the company's stock valued at $1,593,000 after acquiring an additional 255,088 shares in the last quarter. Nantahala Capital Management LLC lifted its stake in Anteris Technologies Global by 1.8% in the 2nd quarter. Nantahala Capital Management LLC now owns 1,693,666 shares of the company's stock valued at $6,419,000 after acquiring an additional 30,000 shares in the last quarter. Finally, MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. bought a new stake in shares of Anteris Technologies Global during the 1st quarter worth approximately $32,000.
Anteris Technologies Global Company Profile
(
Get Free Report)
Anteris Technologies Global Corp. engages in the development and commercialization of medical devices for heart diseases. The company was founded in 1999 and is headquartered in Eagan, MN.
Read More
Before you consider Anteris Technologies Global, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Anteris Technologies Global wasn't on the list.
While Anteris Technologies Global currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.